Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 143-150 , November 2006

Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer

  • Guido B. van den Broek

      Affiliations

    • Department of Head and Neck Oncology and Surgery
    • Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Guido B. van den Broek, Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
    • ,
  • Alfons J.M. Balm

      Affiliations

    • Department of Head and Neck Oncology and Surgery
    • Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • Michiel W.M. van den Brekel

      Affiliations

    • Department of Head and Neck Oncology and Surgery
    • Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • Michael Hauptmann

      Affiliations

    • Molecular Biology
    • ,
  • Jan H. Schornagel

      Affiliations

    • Medical Oncology, and
    • ,
  • Coen R.N. Rasch

      Affiliations

    • Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 31 January 2006 ,Revised 7 September 2006 ,Accepted 12 September 2006.

References 

  1. Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92–98
  2. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–1804
  3. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081–2086
  4. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69–76
  5. Jeremic B, Shibamoto Y, Stanisavljevic B, Milojevic L, Milicic B, Nikolic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 1997;43:29–37
  6. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;16:1318–1324
  7. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–1952
  8. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–1944
  9. Allal AS, Bieri S, Miralbell R, Dulguerov P, Bardina A, Lehmann W, et al. Combined concomitant boost radiotherapy and chemotherapy in stage III–IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone. Ann Oncol. 1997;8:681–684
  10. Balm AJ, Ackerstaff AH, Hilgers FJ, Gregor RT, Bos KE. Psychologic aspects of major head and neck reconstructive surgery. Facial Plast Surg. 1995;11:91–98
  11. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253–262
  12. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB, Flick P, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 1997;38:263–271
  13. Balm AJ, Rasch CR, Schornagel JH, Hilgers FJ, Keus RB, Schultze-Kool L, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004;26:485–493
  14. Homma A, Furuta Y, Suzuki F, Oridate N, Hatakeyama H, Nagahashi T, et al. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer. Head Neck. 2005;27:65–71
  15. Robbins KT, Kumar P, Wong FS, Hartsell WF, Flick P, Palmer R, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687–693
  16. Sobin LH, Wittekind C. TNM classification of malignant tumours. International Union Against Cancer. 5th ed.. New York: John Wiley & Sons; 1997;
  17. van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Tan IB, et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer. 2004;101:1809–1817
  18. Bartelink H, Van den BW, Horiot JC, Jager J, van GM. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial. Eur J Cancer. 2002;38:667–673
  19. Franchin G, Gobitti C, Minatel E, Barzan L, De PA, Boz G, et al. Simultaneous radiochemotherapy in the treatment of inoperable, locally advanced head and neck cancers. A single-institution study. Cancer. 1995;75:1025–1029
  20. Glaser MG, Leslie MD, O’Reilly SM, Cheesman AD, Newlands ES. Weekly cisplatinum concomitant with radical radiotherapy in the treatment of advanced head and neck cancer. Clin Oncol (R Coll Radiol). 1993;5:286–289
  21. Homma A, Shirato H, Furuta Y, Nishioka T, Oridate N, Tsuchiya K, et al. Randomized phase II trial of concomitant chemoradiotherapy using weekly carboplatin or daily low-dose cisplatin for squamous cell carcinoma of the head and neck. Cancer J. 2004;10:326–332
  22. Marcial VA, Pajak TF, Mohiuddin M, Cooper JS, al Sarraf M, Mowry PA, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer. 1990;66:1861–1868
  23. van Bokhorst-de van der Schuer, van Leeuwen PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86:519–527

PII: S0167-8140(06)00478-6

doi: 10.1016/j.radonc.2006.09.002

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 143-150 , November 2006

Article Tools

* Image Usage & Resolution